Clinical Trial Update: Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 pediatric trial evaluating palbociclib in combination with chemotherapy for recurrent or refractory solid tumors, including Ewing sarcoma, rhabdoid tumo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Intrinsic Pontine Glioma
• Ewing Sarcoma
• Medulloblastoma
• Neuroblastoma
• Rhabdoid Tumor
• Rhabdomyosarcoma

Drugs mentioned

• Palbociclib (palbociclib)

Snippet

Sponsor: Pfizer | Conditions: Ewing Sarcoma, Solid Tumors | Phase 2 | Status: ACTIVE_NOT_RECRUITING